Sector pending / Surgical and Medical Instruments and ApparatusUpdated 2026-05-10 22:07 UTC

FRA/UG2 stock hub

FRA/UG2 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/UG2is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

396.6M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/UG2FRA/UG2

—

Loading chart…

In the news

Latest news · FRA/UG2

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-17.5

P25 n/aP50 n/aP75 n/a

ROIC-13.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/UG2 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

181

Groups with data

Currency

USD

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	675
Employees Change	-73%
Employees Change Percent	-9.76
Enterprise value	EUR 374.2M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Surgical and Medical Instruments and Apparatus
Last refreshed	2026-05-10
Market cap	EUR 396.6M
Price	EUR 9.5
Price currency	EUR
Rev Per Employee	393,341.43x
Sic	3841
Symbol	fra/UG2
Website	https://www.angiodynamics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.7%
EV Earnings	-14.09x
EV/EBITDA	247.85x
EV/FCF	294.17x
EV/Sales	1.4x
FCF yield	0.32%
P/B ratio	2.7x
P/S ratio	1.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-6.52%
EBITDA Margin	-0.21%
FCF margin	0.48%
Gross margin	54.3%
Gross Profit	EUR 144.2M
Gross Profit Growth	10.61%
Gross Profit Growth Q	6.75%
Gross Profit Growth3 Y	-0.77%
Gross Profit Growth5 Y	3.42%
Net Income	EUR -26.6M
Pretax Margin	-10%
Profit Margin	-10%
Profit Per Employee	EUR -39,352
ROA	-4.68
Roa5y	-3.16
ROCE	-10.51
ROE	-17.47
Roe5y	-21.38
ROIC	-13.94

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.06%
Cagr1y	25.85%
Cagr3y	6.79%
Cagr5y	-13.66%
FCF Growth5 Y	-31.17%
OCF Growth10 Y	-19.07%
OCF Growth5 Y	-22.37%
Revenue Growth	10.73x
Revenue Growth Q	8.92x
Revenue Growth3 Y	-2.13x
Revenue Growth5 Y	2.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.15
Assets	EUR 220.6M
Cash	EUR 32M
Current Assets	EUR 131.9M
Current Liabilities	EUR 56M
Debt	EUR 9.6M
Debt EBITDA	EUR 6.41
Debt Equity	EUR 0.07
Debt FCF	EUR 7.58
Equity	EUR 146.7M
Interest Coverage	-68.17
Liabilities	EUR 73.9M
Long Term Assets	EUR 88.7M
Long Term Liabilities	EUR 17.9M
Net Cash	EUR 22.4M
Net Cash By Market Cap	EUR 5.64
Net Cash Growth	-22.45%
Net Debt Equity	EUR -0.15
Net Debt FCF	EUR -17.58
Tangible Book Value	EUR 91.3M
Tangible Book Value Per Share	EUR 2.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.35
Inventory Turnover	2.36
Net Working Capital	EUR 45.2M
Quick ratio	1.26
Working Capital	EUR 75.7M
Working Capital Turnover	EUR 2.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-10.14%
1Y total return	25.83%
200-day SMA	9.35
3Y total return	21.8%
50-day SMA	9.23
50-day SMA vs 200-day SMA	50under200
5Y total return	-52.02%
All Time High	27
All Time High Change	-64.81%
All Time High Date	2021-11-05
All Time Low	4.76
All Time Low Change	99.58%
All Time Low Date	2024-03-18
ATR	0.29
Ch YTD	-11.21
High	9.55
High52	13.2
High52 Date	2026-01-06
High52ch	-28.03%
Low	9.5
Low52	7
Low52 Date	2025-08-08
Low52ch	35.71%
Ma50ch	2.91%
Price vs 200-day SMA	1.59%
RSI	55.11
RSI Monthly	51.44
RSI Weekly	51.41
Sharpe ratio	0.51x
Sortino ratio	0.85
Total Return	-1.55%
Tr YTD	-11.21
Tr1m	13.1%
Tr1w	2.15%
Tr3m	6.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -17.3M
Operating margin	-6.52

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	34,967,092%
Net Borrowing	-312,050
Shares Insiders	9.33%
Shares Institutions	86.08%
Shares Qo Q	0.13%
Shares Yo Y	1.55%
Short Ratio	5.34

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -8.6M
Average Volume	0x
Bv Per Share	3.52
CAPEX	EUR -2.5M
Ch10y	-10.14
Ch1m	13.1
Ch1w	2.15
Ch1y	25.83
Ch3m	6.74
Ch3y	21.8
Ch5y	-52.02
Ch6m	-7.77
Change	-0.52%
Change From Open	0
Close	9.55
Days Gap	-0.52
Depreciation Amortization	16,782,015.9
Earnings Date	2026-07-13
EBIT	EUR -17.3M
EBITDA	EUR -557,712
EPS	EUR -0.64
F Score	5
FCF	EUR 1.3M
FCF EV Yield	0.34x
Financing CF	-4,314,437
Fiscal Year End	May
Founded	1,988
Income Tax	EUR 10,156
Investing CF	-6,179,683
Is Primary Listing	0
Last Earnings Date	2026-04-02
Last Report Date	2026-02-28
Ma150	9.72
Ma150ch	-2.26%
Ma20	9.16
Ma20ch	3.77%
Net CF	-5,881,785
Next Earnings Date	2026-07-13
Open	9.5
P FCF Ratio	311.8
P OCF Ratio	105.4
Position In Range	0
Ppne	29,297,087.1
Price Date	2026-05-08
Ptbv Ratio	4.34
Relative Volume	20x
Revenue	265,505,468x
SBC By Revenue	3.72x
Share Based Comp	9,889,862
Tax By Revenue	0x
Tr6m	-7.77%
Volume	0
Z Score	1.88

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/UG2 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/UG2 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/UG2?

Insider, institutional, and short-interest positioning.

Institutional ownership

+86.1%

Share of float held by funds and institutions

Insider ownership

+9.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/UG2 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.1

Neutral momentum band

Price vs 200-day MA

+1.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.51

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/UG2

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/UG2 stock rating?

fra/UG2 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/UG2 analysis?

The full report lives at /stocks/fra/UG2/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/UG2?

The latest report frames fra/UG2 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/UG2 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.